non-invasive DME therapy - Business-News-Today.com

🧬 Interested in pharma, biotech and medical device news? Visit PharmaDeviceNews.com →

Business news, market intelligence, and global industry analysis.

The Latest

AppLovin company profile: How Axon AI is taking performance advertising beyond mobile gaming

Infographic showing the Rincon lithium project in Salta, Argentina, with a lithium processing facility and key figures including a US$2.5 billion cost, 60,000-tonne annual capacity, and a 2028 first-production target.

Rincon lithium project: US$2.5bn cost, 60,000tpa capacity, DLE technology and 2028 production timeline

Supreme Court says children have fundamental right to internet access, rejects blanket bans

Editorial infographic showing affordable fragrance mists becoming a growth area for beauty companies, with product imagery and panels highlighting stronger US mass-market fragrance growth, new launches from major beauty groups, and the key business question of whether lower-priced scents can drive repeat purchases.

Why L’Oréal, Coty and Unilever are betting on affordable fragrance mists

Rezolute, Inc. Announces Positive Topline Results in Phase 2 Study of RZ402 for DME Treatment

Read More

Pharma Industry News

Rezolute’s Phase 2 trial of RZ402 shows significant CST reduction in DME patients

Rezolute, Inc. (Nasdaq: RZLT), a leader in the development of novel therapies for serious metabolic and rare diseases,…

byPallavi Madhiraju

May 22, 2024

web analytics